Paying pharmacies more for dispensing medications will raise prescription drug costs without improving value.
For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans.
Today, spending on biologic drugs makes up 43% of total drug spending. This is a growing area of new innovation for a multitude of therapeutic areas, and also an area of growing cost.
For America’s pharmacy benefit managers, PBMs, our mission is simple: increase affordable access to prescription drugs for everyone. We believe care should be patient-focused, equitable, and affordable.
PCMA believes that organizational and employee success require a diverse, equitable, and inclusive workforce and a culture that embraces and encourages different perspectives.
PCMA has signed on to the CEO Action for Diversity & Inclusion™ pledge. Read more here.
PCMA released a series of videos showcasing the value PBMs provide employers.
PBMs have distinct business processes that differentiate them in the market, but PBMs also adhere to stringent accreditation standards, the terms of negotiated contracts, and legal requirements.
Learn MoreSeptember 13, 2021
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and...
Keep ReadingSeptember 10, 2021
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and...
Keep ReadingSeptember 24, 2021
Former FDA Commissioner Scott Gottlieb said the COVID-19 surge driven by the Delta variant could be the last major wave...
Keep ReadingSeptember 24, 2021
State Medicaid programs should cover Biogen and Eisai's Alzheimer's disease drug Aduhelm as an outpatient drug, said John Coster, director...
Keep Reading
